Head-to-head comparison
boostAGErx vs NewSelf
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
boostAGErx is a longevity-focused telehealth service selling compounded GLP-1 weight management alongside peptide therapy.
$95/mo (billed every 4 weeks) sema · $145/mo (billed every 4 weeks) tirz · Verified August 2026
Marked down on: Billing runs on a 28-day cycle rather than a calendar month — thirteen charges a year, so the $145 tirzepatide rate is $1,885 a year, an effective $157/mo
Desk Score
NewSelf offers compounded semaglutide+ (with B12/Glycine, from $99.97/mo) and compounded tirzepatide+ (with B6/Glycine, from $144.49/mo).
$100/mo sema · $144/mo tirz · Verified July 2026
Marked down on: Not available in Mississippi and Louisiana
FDAWarning letter issued to NewSelf Limited dba NewSelf in February 2026. See the FDA warning-letter database.
NewSelf takes this head-to-head with the higher Desk Score, 79/100 (C+) against 72/100 (C) for boostAGErx. boostAGErx still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
boostAGErx
72/100
C
NewSelf
79/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | boostAGErx | NewSelf |
|---|---|---|
| Semaglutide | $95/mobilled every 4 weeks$95/mo (billed every 28 days, compounded) | $100/mo$100/mo (compounded) |
| Tirzepatide | $145/mobilled every 4 weeks$145/mo (billed every 28 days, compounded) | $144/mo$144/mo (compounded) |
| Coverage | All 50 states | 49 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Cost-sensitive shoppers comfortable prepaying 12 months for low-cost compounded GLP-1. | Lowest-cost compounded GLP-1 with pharmacy quality transparency. |
| Desk Score | 72/100C | 79/100C+ |
The verdict
Desk pick — NewSelfNewSelf takes this head-to-head with the higher Desk Score, 79/100 (C+) against 72/100 (C) for boostAGErx. boostAGErx still holds its ground where its strengths line up with yours.
Choose boostAGErx if…
Cost-sensitive shoppers comfortable prepaying 12 months for low-cost compounded GLP-1.
$95/mo (billed every 4 weeks) sema · $145/mo (billed every 4 weeks) tirz · All 50 states
Choose NewSelf if…
Lowest-cost compounded GLP-1 with pharmacy quality transparency.
$100/mo sema · $144/mo tirz · 49 states
FDAWarning letter issued to NewSelf Limited dba NewSelf in February 2026. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: boostAGErx · NewSelf.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- boostAGErx vs CoreAge Rx
- CoreAge Rx vs NewSelf
- boostAGErx vs yourEra
- NewSelf vs Sunlight
- boostAGErx vs Sunlight
- NewSelf vs Pepti
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.